{"id":"amlodipine-benazepril","safety":{"commonSideEffects":[{"rate":"7-15","effect":"Headache"},{"rate":"5-10","effect":"Dizziness"},{"rate":"3-8","effect":"Fatigue"},{"rate":"2-8","effect":"Peripheral edema"},{"rate":"2-5","effect":"Cough"},{"rate":"1-3","effect":"Hyperkalemia"}]},"_chembl":{"chemblId":"CHEMBL1200402","moleculeType":"Small molecule","molecularWeight":"567.06"},"_dailymed":{"setId":"ff807933-7433-4f8c-9d09-02a57e51d0fc","title":"AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE CAPSULE [PD-RX PHARMACEUTICALS, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Amlodipine is a dihydropyridine calcium channel blocker that prevents calcium influx into vascular smooth muscle cells, causing vasodilation. Benazepril is an ACE inhibitor that blocks the conversion of angiotensin I to angiotensin II, reducing vasoconstriction and aldosterone secretion. The combination provides additive antihypertensive effects through these distinct mechanisms.","oneSentence":"Amlodipine relaxes blood vessels by blocking calcium channels, while benazepril lowers blood pressure by inhibiting angiotensin-converting enzyme (ACE), together reducing hypertension through complementary pathways.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:36:28.227Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"}]},"trialDetails":[{"nctId":"NCT07486453","phase":"PHASE1","title":"Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets","status":"NOT_YET_RECRUITING","sponsor":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","startDate":"2026-03-09","conditions":"Primary Hypertension","enrollment":60},{"nctId":"NCT07262710","phase":"","title":"Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study","status":"NOT_YET_RECRUITING","sponsor":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","startDate":"2025-12-01","conditions":"Post-stroke Pneumonia","enrollment":13656},{"nctId":"NCT00834977","phase":"PHASE1","title":"Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2004-04","conditions":"Healthy","enrollment":48},{"nctId":"NCT00835367","phase":"PHASE1","title":"Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fed Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2004-03","conditions":"Healthy","enrollment":68},{"nctId":"NCT00649519","phase":"PHASE1","title":"Fasting Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2004-05","conditions":"Healthy","enrollment":54},{"nctId":"NCT00649402","phase":"PHASE1","title":"Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2004-05","conditions":"Healhty","enrollment":64},{"nctId":"NCT00170950","phase":"PHASE3","title":"Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension","status":"TERMINATED","sponsor":"Novartis","startDate":"2003-10","conditions":"Hypertension","enrollment":11506},{"nctId":"NCT03682692","phase":"PHASE4","title":"ACEI/CCB Versus ACEI/DIU Combination Antihypertensive Therapy in Chinese Hypertensive Patients (ACvAD)","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2018-06-01","conditions":"Hypertension","enrollment":560},{"nctId":"NCT04467931","phase":"","title":"ACEI or ARB and COVID-19 Severity and Mortality in US Veterans","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-01-19","conditions":"Hypertension, COVID","enrollment":22213},{"nctId":"NCT04330300","phase":"PHASE4","title":"Coronavirus (COVID-19) ACEi/ARB Investigation","status":"SUSPENDED","sponsor":"National University of Ireland, Galway, Ireland","startDate":"2020-04-30","conditions":"Hypertension, COVID-19","enrollment":2414},{"nctId":"NCT00139555","phase":"PHASE4","title":"Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension","status":"COMPLETED","sponsor":"Novartis","startDate":"2004-07","conditions":"Hypertension, Left Ventricular Hypertrophy","enrollment":125},{"nctId":"NCT00000620","phase":"PHASE3","title":"Action to Control Cardiovascular Risk in Diabetes (ACCORD)","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"1999-09","conditions":"Atherosclerosis, Cardiovascular Diseases, Hypercholesterolemia","enrollment":10251},{"nctId":"NCT00171366","phase":"PHASE3","title":"A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.","status":"COMPLETED","sponsor":"Novartis","startDate":"2004-07","conditions":"Hypertension","enrollment":1422},{"nctId":"NCT01603940","phase":"PHASE4","title":"Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine","status":"COMPLETED","sponsor":"Hospital Universitario Pedro Ernesto","startDate":"2012-05","conditions":"Hypertension, Diabetes Mellitus","enrollment":30},{"nctId":"NCT00185120","phase":"PHASE4","title":"Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2005-09","conditions":"Hypertension","enrollment":152},{"nctId":"NCT01505998","phase":"PHASE1","title":"Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2007-03","conditions":"Fed","enrollment":49},{"nctId":"NCT01506011","phase":"PHASE1","title":"Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fasting Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2007-03","conditions":"Fasting","enrollment":50},{"nctId":"NCT00136851","phase":"PHASE4","title":"Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2004-12","conditions":"Hypertension","enrollment":259},{"nctId":"NCT00367978","phase":"PHASE4","title":"Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Novartis","startDate":"2001-12","conditions":"Hypertension","enrollment":275},{"nctId":"NCT01375322","phase":"PHASE4","title":"ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria","status":"COMPLETED","sponsor":"TSH Biopharm Corporation Limited","startDate":"2007-06","conditions":"Hypertension, Diabetes Mellitus, Type 2, Albuminuria","enrollment":226},{"nctId":"NCT00136773","phase":"PHASE4","title":"Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Novartis","startDate":"2003-04","conditions":"Albuminuria","enrollment":332},{"nctId":"NCT01155908","phase":"PHASE1","title":"Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Non-fasting (Fed) Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2005-04","conditions":"Healthy","enrollment":48},{"nctId":"NCT01155895","phase":"PHASE1","title":"Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Fasting Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2004-03","conditions":"Healthy","enrollment":54},{"nctId":"NCT00234871","phase":"PHASE4","title":"Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)","status":"COMPLETED","sponsor":"Abbott","startDate":"2004-01","conditions":"Hypertension, Diabetes, Proteinuria","enrollment":357},{"nctId":"NCT00684489","phase":"NA","title":"Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2003-09","conditions":"Hypertension","enrollment":52}],"_emaApprovals":[],"_faersSignals":[{"count":104,"reaction":"FATIGUE"},{"count":89,"reaction":"DRUG INEFFECTIVE"},{"count":87,"reaction":"NAUSEA"},{"count":83,"reaction":"DIARRHOEA"},{"count":59,"reaction":"DIZZINESS"},{"count":57,"reaction":"HEADACHE"},{"count":54,"reaction":"COMPLETED SUICIDE"},{"count":54,"reaction":"DYSPNOEA"},{"count":47,"reaction":"PAIN"},{"count":46,"reaction":"ARTHRALGIA"}],"_approvalHistory":[],"publicationCount":46,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Amtrel®"],"phase":"marketed","status":"active","brandName":"Amlodipine+Benazepril","genericName":"Amlodipine+Benazepril","companyName":"TSH Biopharm Corporation Limited","companyId":"tsh-biopharm-corporation-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Amlodipine relaxes blood vessels by blocking calcium channels, while benazepril lowers blood pressure by inhibiting angiotensin-converting enzyme (ACE), together reducing hypertension through complementary pathways. Used for Hypertension.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}